KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Current Deferred Revenue (2017 - 2025)

Historic Current Deferred Revenue for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to $56.4 million.

  • Guardant Health's Current Deferred Revenue rose 7353.85% to $56.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.4 million, marking a year-over-year increase of 7353.85%. This contributed to the annual value of $41.6 million for FY2024, which is 8165.94% up from last year.
  • According to the latest figures from Q3 2025, Guardant Health's Current Deferred Revenue is $56.4 million, which was up 7353.85% from $60.7 million recorded in Q2 2025.
  • Over the past 5 years, Guardant Health's Current Deferred Revenue peaked at $60.7 million during Q2 2025, and registered a low of $7.3 million during Q3 2021.
  • For the 5-year period, Guardant Health's Current Deferred Revenue averaged around $25.2 million, with its median value being $21.2 million (2022).
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first crashed by 2962.47% in 2021, then surged by 13443.71% in 2024.
  • Guardant Health's Current Deferred Revenue (Quarter) stood at $11.3 million in 2021, then skyrocketed by 87.18% to $21.2 million in 2022, then grew by 8.02% to $22.9 million in 2023, then soared by 81.66% to $41.6 million in 2024, then surged by 35.58% to $56.4 million in 2025.
  • Its Current Deferred Revenue stands at $56.4 million for Q3 2025, versus $60.7 million for Q2 2025 and $44.0 million for Q1 2025.